Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Genovax s.r.l.
DescriptionTolerogenic vaccine that contains a fusion protein consisting of Fc region of immunoglobulin linked to a synthetic peptide made up of amino acid sequences from anti-DNA antibodies
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationLupus
Indication DetailsTreat systemic lupus erythematosus (SLE)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today